| Productivity costs associated with metastatic breast cancer in younger, midlife, and older women JG Trogdon, X Liu, KE Reeder‐Hayes, J Rotter, DU Ekwueme, ... Cancer 126 (18), 4118-4125, 2020 | 24 | 2020 |
| Risk of Venous Thromboembolism by Cancer Type: A Network Meta-Analysis MB Betts, X Liu, DR Junqueira, K Fahrbach, B Neupane, S Ronnebaum, ... Seminars in Thrombosis and Hemostasis, 2024 | 2 | 2024 |
| Antiplatelet Treatment Patterns and Outcomes for Secondary Stroke Prevention in the United Kingdom X Liu, J Jiang, D Li, J Horrow, H Tamada, A Kahl, V Hariharan, A Avinav, ... Cardiology and Therapy 12 (4), 675-687, 2023 | 1 | 2023 |
| Heart Failure Across the Range of Mildly Reduced and Preserved Ejection Fraction in the United States SJ Greene, JA Spertus, W Tang, A Kang, Y Zhong, MC Myers, S Shen, ... Circulation: Heart Failure 16 (5), e010430, 2023 | 1 | 2023 |
| Trends and factors associated with outpatient anticoagulant treatment initiation among VTE patients with active cancer AD Dhamane, S Shah, V Noxon, R Bruette, M Ferri, X Liu, J Jiang, X Luo Thrombosis Research 224, 52-59, 2023 | 1 | 2023 |
| Incidence and delays of a new clinical atrial fibrillation diagnosis following an atrial fibrillation detection signal on a personal electrocardiogram device available to consumers SD Deitelzweig, AD Dhamane, XL Liu, SH Han, RS Subash, ... European Heart Journal 44 (Supplement_2), ehad655. 421, 2023 | | 2023 |
| Comparative effectiveness and safety of apixaban and low-molecular weight heparin among patients with venous thromboembolism and active cancer in an extended treatment setting AT Cohen, AD Dhamane, X Liu, S Han, R Stellhorn, Q Zhang, R Singh, ... European Heart Journal 44 (Supplement_2), ehad655. 2850, 2023 | | 2023 |
| Anticoagulant therapy beyond primary treatment among active cancer and non-cancer patients with venous thromboembolism in the United States AT Cohen, AD Dhamane, X Liu, S Han, R Stellhorn, R Singh, J Wang, ... European Heart Journal 44 (Supplement_2), ehad655. 2851, 2023 | | 2023 |
| Using a network meta-analysis (NMA) to estimate the risk of venous thromboembolism (VTE) by cancer site ADD Xuejun Liu, Marissa Betts, Daniela R Junqueira, Kyle Fahrbach, Binod ... The International Society on Thrombosis and Haemostasis 2023 Congress, 2023 | | 2023 |
| Impact of COVID-19 on thromboembolic events and mortality among patients with non-valvular atrial fibrillation receiving oral anticoagulants XL Inmaculada Hernandez, Amol Dhamane The International Society on Thrombosis and Haemostasis 2023 Congress, 2023 | | 2023 |
| Heart failure across the range of preserved ejection fraction in United States clinical practice S Greene, JA Spertus, W Tang, A Kang, Y Zhong, M Myers, S Shen, ... European Heart Journal 43 (Supplement_2), ehac544. 863, 2022 | | 2022 |
| Anticoagulant treatment patterns and thromboembolic events by tumor type among patients with VTE and cancer AD Dhamane, V Noxon, R Bruette, S Shah, M Ferri, X Liu, J Jang, X Luo European Heart Journal 43 (Supplement_2), ehac544. 1906, 2022 | | 2022 |
| Factors Associated with Anticoagulant Treatment Initiation Among Venous Thromboembolism Patients with Cancer XL Shrushti Shah, Amol D Dhamane, Mauricio Ferri, Robert Bruette, Virginia ... International Society on Thrombosis and Haemostasis, PB0446, 2022 | | 2022 |
| PCV42 Antiplatelet Treatment Patterns for Secondary Stroke Prevention in the United Kingdom J Jiang, D Li, J Horrow, H Tamada, A Kahl, V Hariharan, A Avinav, X Liu, ... Value in Health 24, S74, 2021 | | 2021 |
